ID   OXSR1_RAT               Reviewed;         528 AA.
AC   A0A8I5ZNK2; A0A8I5ZZD5;
DT   13-SEP-2023, integrated into UniProtKB/Swiss-Prot.
DT   25-MAY-2022, sequence version 1.
DT   24-JUL-2024, entry version 12.
DE   RecName: Full=Serine/threonine-protein kinase OSR1;
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:O95747};
DE   AltName: Full=Oxidative stress-responsive 1 protein {ECO:0000303|PubMed:16083423};
GN   Name=Oxsr1 {ECO:0000312|RGD:1310466};
GN   Synonyms=Osr1 {ECO:0000303|PubMed:16083423};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   ACTIVITY REGULATION, PHOSPHORYLATION AT THR-185 AND SER-325, AND
RP   MUTAGENESIS OF ASP-164 AND THR-185.
RX   PubMed=16083423; DOI=10.1042/bj20051180;
RA   Vitari A.C., Deak M., Morrice N.A., Alessi D.R.;
RT   "The WNK1 and WNK4 protein kinases that are mutated in Gordon's
RT   hypertension syndrome phosphorylate and activate SPAK and OSR1 protein
RT   kinases.";
RL   Biochem. J. 391:17-24(2005).
RN   [3]
RP   FUNCTION, ACTIVITY REGULATION, AND PHOSPHORYLATION AT SER-325.
RX   PubMed=22544747; DOI=10.1074/jbc.m111.319418;
RA   Inoue K., Furukawa T., Kumada T., Yamada J., Wang T., Inoue R., Fukuda A.;
RT   "Taurine inhibits K+-Cl- cotransporter KCC2 to regulate embryonic
RT   Cl- homeostasis via with-no-lysine (WNK) protein kinase signaling
RT   pathway.";
RL   J. Biol. Chem. 287:20839-20850(2012).
CC   -!- FUNCTION: Effector serine/threonine-protein kinase component of the
CC       WNK-SPAK/OSR1 kinase cascade, which is involved in various processes,
CC       such as ion transport, response to hypertonic stress and blood pressure
CC       (PubMed:22544747). Specifically recognizes and binds proteins with a
CC       RFXV motif (By similarity). Acts downstream of WNK kinases (WNK1, WNK2,
CC       WNK3 or WNK4): following activation by WNK kinases, catalyzes
CC       phosphorylation of ion cotransporters, such as SLC12A1/NKCC2,
CC       SLC12A2/NKCC1, SLC12A3/NCC, SLC12A5/KCC2 or SLC12A6/KCC3, regulating
CC       their activity (By similarity). Mediates regulatory volume increase in
CC       response to hyperosmotic stress by catalyzing phosphorylation of ion
CC       cotransporters SLC12A1/NKCC2, SLC12A2/NKCC1 and SLC12A6/KCC3 downstream
CC       of WNK1 and WNK3 kinases (By similarity). Phosphorylation of Na-K-Cl
CC       cotransporters SLC12A2/NKCC1 and SLC12A2/NKCC1 promote their activation
CC       and ion influx; simultaneously, phosphorylation of K-Cl cotransporters
CC       SLC12A5/KCC2 and SLC12A6/KCC3 inhibit their activity, blocking ion
CC       efflux (PubMed:22544747). Acts as a regulator of NaCl reabsorption in
CC       the distal nephron by mediating phosphorylation and activation of the
CC       thiazide-sensitive Na-Cl cotransporter SLC12A3/NCC in distal convoluted
CC       tubule cells of kidney downstream of WNK4 (By similarity). Also acts as
CC       a regulator of angiogenesis in endothelial cells downstream of WNK1 (By
CC       similarity). Acts as an activator of inward rectifier potassium
CC       channels KCNJ2/Kir2.1 and KCNJ4/Kir2.3 downstream of WNK1: recognizes
CC       and binds the RXFXV/I variant motif on KCNJ2/Kir2.1 and KCNJ4/Kir2.3
CC       and regulates their localization to the cell membrane without mediating
CC       their phosphorylation (By similarity). Phosphorylates RELL1, RELL2 and
CC       RELT (By similarity). Phosphorylates PAK1. Phosphorylates PLSCR1 in the
CC       presence of RELT (By similarity). {ECO:0000250|UniProtKB:O95747,
CC       ECO:0000269|PubMed:22544747}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:O95747};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:O95747};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:O95747};
CC   -!- ACTIVITY REGULATION: Activated following phosphorylation by WNK kinases
CC       (WNK1, WNK2, WNK3 or WNK4). {ECO:0000269|PubMed:16083423,
CC       ECO:0000269|PubMed:22544747}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O95747}.
CC   -!- PTM: Phosphorylation at Thr-185 by WNK kinases (WNK1, WNK2, WNK3 or
CC       WNK4) is required for activation (PubMed:16083423). Autophosphorylated;
CC       promoting its activity (By similarity). {ECO:0000250|UniProtKB:O95747,
CC       ECO:0000269|PubMed:16083423}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   SMR; A0A8I5ZNK2; -.
DR   iPTMnet; A0A8I5ZNK2; -.
DR   PhosphoSitePlus; A0A8I5ZNK2; -.
DR   Ensembl; ENSRNOT00000099478.1; ENSRNOP00000079676.1; ENSRNOG00000013136.7.
DR   Ensembl; ENSRNOT00055011111; ENSRNOP00055008693; ENSRNOG00055006782.
DR   Ensembl; ENSRNOT00060032224; ENSRNOP00060026236; ENSRNOG00060018699.
DR   Ensembl; ENSRNOT00065006891; ENSRNOP00065004712; ENSRNOG00065004767.
DR   AGR; RGD:1310466; -.
DR   RGD; 1310466; Oxsr1.
DR   GeneTree; ENSGT00940000154621; -.
DR   OMA; TAPYHRF; -.
DR   PRO; PR:A0A8I5ZNK2; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006884; P:cell volume homeostasis; ISO:RGD.
DR   GO; GO:0071474; P:cellular hyperosmotic response; ISO:RGD.
DR   GO; GO:0071476; P:cellular hypotonic response; ISO:RGD.
DR   GO; GO:1990869; P:cellular response to chemokine; ISO:RGD.
DR   GO; GO:0038116; P:chemokine (C-C motif) ligand 21 signaling pathway; ISO:RGD.
DR   GO; GO:0038146; P:chemokine (C-X-C motif) ligand 12 signaling pathway; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:1901380; P:negative regulation of potassium ion transmembrane transport; ISO:RGD.
DR   GO; GO:0007231; P:osmosensory signaling pathway; ISO:RGD.
DR   GO; GO:0010820; P:positive regulation of T cell chemotaxis; ISO:RGD.
DR   GO; GO:0070294; P:renal sodium ion absorption; ISO:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   CDD; cd06610; STKc_OSR1_SPAK; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR024678; Kinase_OSR1/WNK_CCT.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR050629; STE20/SPS1-PAK.
DR   PANTHER; PTHR48012:SF1; SERINE_THREONINE-PROTEIN KINASE OSR1; 1.
DR   PANTHER; PTHR48012; STERILE20-LIKE KINASE, ISOFORM B-RELATED; 1.
DR   Pfam; PF12202; OSR1_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cytoplasm; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:O95747"
FT   CHAIN           2..528
FT                   /note="Serine/threonine-protein kinase OSR1"
FT                   /id="PRO_0000458460"
FT   DOMAIN          17..291
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          313..350
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          394..429
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        313..336
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        146
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         23..31
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         46
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95747"
FT   MOD_RES         185
FT                   /note="Phosphothreonine; by WNK1"
FT                   /evidence="ECO:0000269|PubMed:16083423"
FT   MOD_RES         310
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O95747"
FT   MOD_RES         324
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95747"
FT   MOD_RES         325
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:16083423,
FT                   ECO:0000269|PubMed:22544747"
FT   MOD_RES         339
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95747"
FT   MOD_RES         347
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95747"
FT   MOD_RES         359
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95747"
FT   MOD_RES         428
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95747"
FT   MUTAGEN         164
FT                   /note="D->A: Abolished serine/threonine-protein kinase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:16083423"
FT   MUTAGEN         185
FT                   /note="T->A: Decreased serine/threonine-protein kinase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:16083423"
FT   MUTAGEN         185
FT                   /note="T->E: Mimics phosphorylation; increased
FT                   serine/threonine-protein kinase activity."
FT                   /evidence="ECO:0000269|PubMed:16083423"
SQ   SEQUENCE   528 AA;  58360 MW;  FAE59BC244AF8BA7 CRC64;
     MSEDSSALPW SINRDDYELQ EVIGSGATAV VQAAYCAPKK ERVAIKRINL EKCQTSMDEL
     LKEIQAMSQC HHPNIVSYYT SFVVKDELWL VMKLLSGGSV LDIIKHIVAK GEHKGGVLDE
     STIATILREV LEGLEYLHKN GQIHRDVKAG NILLGEDGSV QIADFGVSAF LATGGDITRN
     KVRKTFVGTP CWMAPEVMEQ VRGYDFKADI WSFGITAIEL ATGAAPYHKY PPMKVLMLTL
     QNDPPSLDTG VQDKEMLKKY GKSFRKMISL CLQKDPEKRP TAAELLRHKF FQKAKNKEFL
     QEKILQRAPT ISERSKKVRR VPGSSGRLHK TEDGGWEWSD DEFDEESEEG KAAISQLRSC
     PTQQHCLCLL QLFSAADPMG TLLQVPEQIS AHLPQPASQM PTQPAQVSLL PPAEPAKPAQ
     ARSSGERSQE TKVPISLVLR LRNSKKELND IRFEFTPGRD TAEGVSQELI SAGLVDGRDL
     VIVAANLQKI VEEPQSNRSV TFKLASGVEG SDIPDDGKLI GFAQLSIS
//
